Karus Therapeutics appoints Simon Kerry as CEO

Southampton, UK – 2 May 2006 – Karus Therapeutics, an emerging biotechnology company and University of Southampton spinout, focused on developing innovative therapeutics to treat cancer and heart disease, has announced the appointment of Simon Kerry as its Chief Executive Officer (CEO). Simon joins Karus from a senior business development position with a European biotech […]